These innovative companies are working to rapidly deliver better solutions to the world’s healthcare challenges.
Origin: San Diego, CA | Leadership: Dinu Sen, CEO
Improves the therapeutic index of small molecule drugs by creating new chemical entities or therapeutic combinations with existing drugs.
Arcturus Therapeutics, Inc
Origin: San Diego, CA | Leadership: Joseph E. Payne, Founder and CEO; Pad Chivukula, Founder and CSO
Arcturus is poised to become an industry leader in RNAi technologies for the treatment of rare orphan diseases.
Clinical Metabolomics (ClinMet)
Origin: Redwood City, CA | Leadership: Yesh Subramanian, CEO
Focus: Diagnostics & Pharma Services
Clinical trial based metabolomics platform for pharma to improve drug efficacy, reduce drug toxicity and identify mechanistic pathways for personalized medicine.
Origin: Houston, Texas | Leadership: Frank Tufaro, CEO
With a focus on brain tumors, we are in clinical development with highly potent oncolytic viruses to trigger anti tumor immunity.
Origin: Ann Arbor, MI | Leadership: Thomas Everist, Chairman
Focus: Personalized Medicine and Diagnostics
Develops and commercializes medically unique molecular and sensor based diagnostics, prognostics and therapeutic selection technologies for cancer and cardiovascular diseases, which help physicians improve medical outcomes and reduce the total cost of care.
Origin: San Diego, CA | Leadership: Undisclosed
Research and development of mechanism-based, proprietary biomarker and in vitro immunodiagnosis products for the early detection of protein amyloid diseases.
Origin: Los Angeles, CA | Leadership: Michel F. Levesque, Founder and Chairman
NeuroGeneration is a clinical stage biotechnology company with neural stem cell products targeting neurological disorders caused by cell loss or injury. It also identifies new targets for endogenous repair in the treatment of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, etc.
Origin: San Diego, CA | Leadership: Adrian Newman-Tancredi, CSO
Design and develop novel small molecule compounds against a number of targets in the CNS targeting treatment-resistant depression, cognitive deficits in schizophrenia, symptomatic treatment of Parkinson's disease and developmental disorders such as Rett syndrome.
Origin: San Diego, CA | Leadership: Henry Pan, CEO
Focus: Biopharmaceutical/Clinical Diagnostics/Bioinformatics
Focused on improving trial outcomes by selecting the right patient cohort, thereby potentially improving drug efficacy in oncology, metabolic disorders, cardiovascular diseases, viral infections and immunological diseases.
Origin: Bologna, Italy | Leadership: Giusepp Giorgini, CEO
Proprietary lab-on-a-chip technology platform designed to individually identify, manipulate and sort specific cells within a heterogeneous population.
Origin: Munich, Germany | Leadership: Robert Hillman
Medical diagnostic systems that provide a comprehensive profile of a patient's coagulation status.
Origin: San Diego, CA | Leadership: Troy Wilson, President & CEO
Discovery and development of small molecule drugs that target signal transduction networks for the treatment of cancer and other diseases.
Origin: Mexico City, Mexico | Leadership: Alberto Osio, Founder & CEO
Focus: Medical Device
Non-invasive treatment to correct presbyopia using personalized contact lenses and specially formulated eye drops.
*Some companies have opted for non-disclosure and are therefore not included in this list.